Wells Fargo takes another step forward as OCC terminates 2021 consent order
A top U.S. banking regulator terminated a 2021 consent order against Wells Fargo for deficiencies in its home lending loss ...
Seeking Alpha18d
Wells Fargo: A Strong Bank, But Is It A Good Buy Right Now?
Wells Fargo has improved efficiency and profitability but lacks significant revenue growth and faces regulatory issues ... 59.6 million last year, a clear sign it’s adapting to a more online ...
Wells Fargo sees path to growth ahead as another regulatory order is lifted
Wells Fargo & Co. on Monday said that regulators had terminated a 2021 enforcement order related to loss-mitigation issues in ...
Healthcare Dive2d
Judge dismisses lawsuit against Wells Fargo over prescription drug costs
The decision could throw cold water on potential copycat suits seeking to hold large, self-funded employers responsible if ...
BenefitsPRO2d
Judge tosses Wells Fargo's ERISA suit over drug benefit management
The case outlined how Wells Fargo used Express Scripts as its pharmacy benefit manager without competitive bidding and ...
Morningstar11d
Wells Fargo says it just had another regulatory order lifted
Over recent weeks, Wells Fargo has said it has made enough improvements to get other regulatory actions lifted - including those related to compliance risk management and an order from the ...
Investing15d
Wells Fargo’s SWOT analysis: stock outlook amid regulatory progress and strategic shifts
Wells Fargo & Company (NYSE:WFC), one of the largest banks in the United States, has been navigating a complex landscape of regulatory challenges, strategic shifts, and market pressures.